ABBV AbbVie Inc.

ABBV AbbVie Inc.

Healthcare · Drug Manufacturers - General

Desk view

Watchingmedium conviction · entry <$195 — not entered
Basis Logged decision ·Entry target
Updated

Market read

Scan convergence 1 scan as of 2026-10-16 1 bear converging

POC $226.40 · VWAP $230.88 · +23.6% vs 12m avg buyer

uptrend vol: normalgaps: stablechurn: quiet as of

Insiders quiet 0 buy / 0 sell · Form 4, 90d

Coverage

3 related campaigns

Watchlists @biotech-scan

ABBV Price Structure

Loading chart…

Loading timeframes…

Peers

Every watchlist ABBV belongs to, members best 30-day change first — ABBV highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.

@biotech-scan
View watchlist →
GRAL+56.9% -13.0%1d -16.2%7d MRNA+49.7% -7.8%1d -3.1%7d DNA+45.5% -12.7%1d -21.0%7d AMGN+14.9% -0.3%1d +4.3%7d ILMN+14.7% -2.0%1d -5.6%7d RARE+12.9% -4.2%1d -6.1%7d A+12.5% -1.5%1d +1.4%7d ISRGE+11.6% -0.3%1d +0.7%7d LLY+10.5% +0.4%1d +6.6%7d DHR+9.9% -1.1%1d +4.2%7d RXRX+8.8% -16.6%1d -20.4%7d ABBV+8.7% +0.7%1d +3.2%7d LEGN+8.7% -6.7%1d -0.8%7d BIIB+7.7% -1.1%1d +3.1%7d TMO+6.4% -0.9%1d +4.9%7d GILD+5.8% -0.8%1d +3.3%7d MDT+2.3% -0.7%1d +7.1%7d REGN+2.1% -0.7%1d +5.9%7d BEAM+1.6% -5.1%1d -8.7%7d IBB-0.2% -2.6%1d -2.2%7d NTLA-0.6% +0.7%1d -12.6%7d IQV-0.7% -1.5%1d +2.7%7d DXCM-1.5% -1.9%1d +2.3%7d IBBQ-1.9% -2.7%1d -2.6%7d VRTX-2.6% -1.8%1d -2.0%7d ALNY-3.1% -0.9%1d -0.4%7d IONS-4.2% -2.7%1d -5.2%7d CRSP-5.7% -4.4%1d -7.8%7d XBI-6.4% -3.6%1d -6.2%7d NVO-6.9% -1.0%1d +0.5%7d BNTX-8.5% -2.8%1d -9.5%7d COGT-9.3% 0.0%1d -4.8%7d INCY-9.4% -0.2%1d +0.3%7d PTGX-9.9% -5.7%1d -10.4%7d KYMR-9.9% -3.1%1d -6.8%7d EDIT-13.3% -3.7%1d -19.0%7d SRPT-13.5% -3.9%1d -4.2%7d BMRN-15.5% -2.4%1d -0.2%7d IMVT-26.5% -2.8%1d -12.3%7d NKTR-46.9% -5.1%1d -13.1%7d

Decision history

3 scored calls · newest first · projection

How to read this: Positive 30-day excess supports an enter call. For pass, avoid, sell, or exit calls, a positive number means the name kept rising after the call.

Jun 27 sell n/a Profit target +2.0% complete
Jun 27 sell n/a Profit target +2.0% complete
May 23 sell n/a Momentum recovery exit +8.5% complete

Next earnings ABBV reports in 13 days Oct 30

Last report Jul 31

Reported the quarter ending 2026-06-30: revenue $16.99B, diluted EPS $2.03, net income $3.61B (SEC filing, revenue corroborated by the desk's provider cache). Across the print the stock moved -4.8% (close before → first close after).

full note →

Against street estimates

How ABBV's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.

8 most recent of 9 quarters · newest report Jul 31 · projection Oct 16

Result
Jul 31 3.613.65 GAAP ≠ +1.1%In line
Apr 29 2.672.65 GAAP ≠ -0.8%In line
Feb 4 2.652.71 GAAP ≠ +2.2%Beat
Oct 31 '25 1.781.86 GAAP ≠ +4.2%Beat
Jul 31 '25 2.912.97 GAAP ≠ +2.1%Beat
Apr 25 '25 2.402.46 GAAP ≠ +2.6%Beat
Jan 31 '25 2.122.16 GAAP ≠ +1.9%In line
Oct 30 '24 2.923.00 GAAP ≠ +2.8%Beat

News (last pull)

Headlines about ABBV from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.

pulled 16 days ago · Oct 1

ABBV research tape

92 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.

scan Biotech Scan — October 16, 2026 brief Everything Bounced but the Chips scan Biotech Scan — October 9, 2026 scan Biotech Scan — October 2, 2026 brief The Suppliers Ran, the Neoclouds Sat, and the 10-Year Hit a 24-Year High
Types
Oct 16 Scan Biotech Scan
IMVTBMRNNKTRINCYNVOCOGTIONSREGN +4 more
Oct 15 Market Brief Everything Bounced but the Chips
ABBVACMRAPDPCTYFMCMANAPPNKRMN +4 more
Oct 9 Scan Biotech Scan
IMVTBMRNNKTRINCYNVOCOGTIONSREGN +4 more
Oct 2 Scan Biotech Scan
NKTRBMRNNVOIMVTIONSINCYALNYREGN +4 more
Oct 1 Market Brief The Suppliers Ran, the Neoclouds Sat, and the 10-Year Hit a 24-Year High
ABBVAIRAMRASMLBAMBOXIDTCTVA +4 more
Sep 28 Desk Move ABBV — claude-trader sell
ABBV
Sep 25 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
Sep 23 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
Sep 18 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
Sep 11 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
Sep 4 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
Aug 28 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
Aug 22 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
Aug 14 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
Aug 8 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
Aug 4 Market Brief The Hardware Complex Fires First, and the Wall Hits Tonight
ALKSAVALAXSMBTSGCDNACGNXAAPLABBV +4 more
Jul 31 Market Brief One Margin Call, One Record Day
AAPLABBVABCLABTACHRACNAMZNMSFT +4 more
Jul 31 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
Jul 31 Catalyst ABBV earnings
ABBV
Jul 30 Market Brief The Block Clears: Citadel Buys the Book, Memory Rips
AAPLABBVABCLABTACHRACNMSFTMETA +4 more
Jul 30 Catalyst ABBV earnings
ABBV
Jul 29 Market Brief The Split Print: Compute Sellers Collect, Compute Buyers Pay
MSFTMETAQCOMARMAAPLAMZNKLACMA +4 more
Jul 28 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
Jul 25 Desk Move ABBV — bench-signals buy
ABBV
Jul 25 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
Jul 17 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
Jul 17 Scan Bargain Bin
AAPLMSFTGOOGLAMZNNVDAMETATSLACRM +4 more
Jul 11 Scan Biotech Scan
ABBVXBIIBBIBBQLABUMRNABIIBLLY +4 more
Jul 11 Scan Bargain Bin
AAPLMSFTGOOGLAMZNNVDAMETATSLACRM +4 more
Jul 7 Scan Biotech Scan
ABBVXBIIBBIBBQLABUMRNABIIBLLY +4 more
Jul 7 Scan Bargain Bin
AAPLMSFTGOOGLAMZNNVDAMETATSLACRM +4 more
Jun 26 Scan Biotech Scan
ABBVXBIIBBIBBQLABUMRNABIIBLLY +4 more
Jun 26 Article Week in Review — The Rotation Gets a Name
SPYQQQDIAIWMRSPMUSNDKAMAT#ai-capex-digestion#memory-supercycle#ai-power-bottleneck +4 more
Jun 26 Article The Rotation Map — What Held, What Got Whacked, and the RSI-20 Trap
SNDKMUALABAMATUNHABBVILMNCAT +4 more
Jun 25 Scan Biotech Scan
CRSPBEAMNTLAALNYLEGNMRNABNTXLLY +4 more
Jun 16 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
May 29 Scan Insider Scan
AAPLABBVABNBADBEAFRMAKAMAMDAMZN +4 more
May 29 Scan Biotech Scan
AABBVALNYAMGNBEAMBIIBBMRNBNTX +4 more
May 29 Update Biotech Candidates
LLYVRTXABBVAMGNGILDTMOCRSPNTLA +3 more
May 29 Scan Bargain Bin Scan
AAPLABBVABNBADBEAMDAMZNANETASML +4 more
Apr 29 Article 🔬 Thesis Pulse
ABBVAPDBRBREOPSFGDGILDHONJNJ +3 more
Apr 28 Article Updated: AbbVie flirts with popular pan-RAS field in up to $1.45B option to acquire Kestrel
ABBV
Apr 28 Scan Biotech Scan
ABBVALNYAMGNBEAMBIIBBMRNBNTXCOGT +4 more
Apr 28 Scan Bargain Bin Scan
ABBVCMEDPZHONJNJLLYLULUMCD +4 more
Apr 27 Reference YOLO Playbook
ABBVAMDARKKARMASASANAVGOBE +4 more
Apr 27 Reference Claude-Trader Playbook
ABBVABTADBEASANAVGOCEGCLXCOP +4 more
Apr 27 Reference Claude-Momentum Playbook
ABBVAMZNARMASANAVGOCRMCRSPCRWD +4 more
Apr 27 Reference Bench-Signals Playbook
ABBVABTADBEAFRMAMDAMKRAMZNARM +4 more
Apr 26 Article Status Report
ABBVAMZNARMBTC-USDCRSPCRWDEEMGDX +4 more
Apr 26 Scan Biotech Scan
ABBVALNYAMGNBEAMBIIBBMRNBNTXCOGT +4 more
Apr 26 Update Biotech Candidates
ABBVAMGNCRSPGILDISRGELLYREGNVRTX
Apr 26 Scan Bargain Bin
ABBVBRK-BCMECRSPHONJNJLLYLULU +4 more
Apr 26 Article Daily Actions
ABBVABTALABALERTAMDAMZNARMAS +4 more
Apr 26 Target ABBV entry-zone — <$195
ABBV
Apr 13 Scan 1 — BIOTECH SCAN
ABBVALNYAMGNBIIBBMRNBNTXGILDINCY +4 more
Apr 13 Scan Bargain Bin Scan
ABBVADBEASANCRMINTUISRGELLYLULU +4 more
Apr 10 Scan Biotech Scan
ABBVALNYAMGNBEAMBIIBBMRNBNTXCRSP +4 more
Apr 10 Update Biotech Candidates
ABBVAMGNCRSPGILDISRGEREGN
Apr 3 Scan Biotech Scan
ABBVALNYAMGNBEAMBIIBBMRNBNTXCRSP +4 more
Apr 3 Article Daily Actions
ABBVABTADBEAGROASBTCCEGCOP +4 more
Mar 31 Article Status Report
ABBVABTADBEAKAMARMBTC-USDCOPCRWD +4 more
Mar 31 Scan Healthcare Scan
ABBVABTAMGNBIIBCVSDXCMGILDISRGE +4 more
Mar 31 Scan Biotech Scan
ABBVALNYAMGNBEAMBIIBBMRNBNTXCRSP +4 more
Mar 26 Scan Insider Universe Scan
AAPLABBVADBEAKAMAMDAMZNARMASML +4 more
Mar 26 Scan Biotech Scan
ABBVALNYAMGNBEAMBIIBBMRNBNTXCRSP +4 more
Mar 26 Scan Bargain Bin
AAPLABBVADBEAKAMAMDAMZNARMASML +4 more
Mar 26 Article Daily Actions
AAOIABBVADBEAEISAMDARMASMLBIIB +4 more
Mar 24 Article Status Report
ABBVECLINDAITBMSFTSYKTMOXHB
Mar 24 Scan Biotech Scan
ABBVALNYAMGNBIIBBMRNBNTXCRSPDHR +4 more
Mar 24 Scan Bargain Bin Scan
ABBVADBEAFRMASANDISDPZGEEHD +4 more
Mar 24 Article Daily Actions
ABBVADBEASBABMRNBTCCOPCRM +4 more
Mar 20 Desk Move BUY ABBV — yolo (2026-03-20, 39.07 shares @ $204.75)
ABBV
Mar 20 Article Market Status Report
ABBVADBEAMKRAMZNARKKASAVGOCEG +4 more
Mar 20 Scan Insider Scan
ABBVADBEAMDAMZNARMASANASMLAVGO +4 more
Mar 20 Desk Move BUY ABBV — claude-trader (2026-03-20, 12.21 shares @ $204.75)
ABBV
Mar 20 Desk Move BUY ABBV — claude-momentum (2026-03-20, 24.42 shares @ $204.75)
ABBV
Mar 20 Scan Biotech Scan
ABBVALNYAMGNBEAMBIIBBMRNBNTXCRSP +4 more
Mar 20 Desk Move BUY ABBV — bench-signals (2026-03-20, 4.88 shares @ $204.75)
ABBV
Mar 20 Scan Bargain Bin Scan
ABBVFXIGDXGEEJEPILLYLOWMCD +4 more
Mar 20 Article Daily Actions
AAPLABBVAMGNAMZNARMASASMLBA +4 more
Mar 13 Scan Biotech Scan
ABBVALNYAMGNBEAMBIIBBMRNBNTXCRSP +4 more
Mar 12 Scan Biotech Scan
ABBVALNYAMGNBEAMBIIBBMRNBNTXCRSP +4 more
Mar 11 Scan Insider Activity Scan
AAPLABBVABNBADBEAFRMAKAMAMDAMZN +4 more
Mar 11 Scan Biotech Scan
ABBVALNYAMGNBEAMBIIBBLUEBMRNBNTX +4 more
Mar 10 Scan Biotech Scan
ABBVALNYAMGNBEAMBIIBBLUEBMRNBNTX +4 more
Mar 4 Scan Discovery Scan
AAAALAAOIAAONAAPAAPLAAUCABBV +4 more
Mar 3 Scan Biotech Scan
ABBVALNYAMGNBEAMBIIBBMYBNTXCRSP +4 more
Mar 3 Scan Bargain Bin Scan
AAPLABBVABNBADBEAMDAMZNANETASML +4 more
Feb 26 Scan Bargain Bin Scan
AAPLABBVABNBADBEAMDAMZNANETASML +4 more
Feb 22 Scan Bargain Bin Scan
AAPLABBVADBEAMDAMZNANETASMLAVGO +4 more
Feb 16 Scan Bargain Bin Scan
AAPLABBVADBEAMZNCOSTCRMDPZGOOGL +4 more
Feb 2 Scan Biotech Universe
ABBVALNYAMGNBEAMBIIBBMRNBNTXDHR +4 more